Oliver Lagore Vanvalin Investment Group Heart Test Laboratories, Inc. Transaction History
Oliver Lagore Vanvalin Investment Group
- $334 Million
- Q1 2024
A detailed history of Oliver Lagore Vanvalin Investment Group transactions in Heart Test Laboratories, Inc. stock. As of the latest transaction made, Oliver Lagore Vanvalin Investment Group holds 70,358 shares of HSCS stock, worth $366,565. This represents 0.0% of its overall portfolio holdings.
Number of Shares
70,358
Previous 84,608
16.84%
Holding current value
$366,565
Previous $14,000
42.86%
% of portfolio
0.0%
Previous 0.01%
Shares
7 transactions
Others Institutions Holding HSCS
# of Institutions
24Shares Held
1.55MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA192KShares$997,9280.0% of portfolio
-
Tradition Wealth Management, LLC180KShares$940,2220.0% of portfolio
-
Northern Trust Corp Chicago, IL165KShares$861,5930.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il123KShares$641,2780.0% of portfolio
-
Hrt Financial LP New York, NY122KShares$638,0420.0% of portfolio
About Heart Test Laboratories, Inc.
- Ticker HSCS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 8,202,550
- Market Cap $42.7M
- Description
- Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional 12-lead resting ECG information. It serves clinics, doctor's offices, urg...